Antisense oligonucleotides companies

Companies

• Biogen FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Antisense oligonucleotides, Bispecific antibodies, Monoclonal antibodies · 260 jobs observed · 509 trials (lead sponsor)

• Dyne Therapeutics Clinical Phase 3

  Waltham, MA · Antisense oligonucleotides, RNA therapeutics · 50 jobs observed · 4 trials (lead sponsor)

• Sarepta Therapeutics, Inc. FDA-approved therapeutic company Clinical Phase 3

  Cambridge, MA · Antisense oligonucleotides, Gene therapy, Gene therapy: AAV · 22 jobs observed · 52 trials (lead sponsor)

• Stoke Therapeutics Clinical Phase 3

  Bedford, MA · Antisense oligonucleotides, RNA therapeutics · 15 jobs observed · 3 trials (lead sponsor)

• Aldebaran Therapeutics

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• Aligos Therapeutics Clinical Phase 2

  South San Francisco, CA · Antisense oligonucleotides, RNA therapeutics, Small molecule · No hiring observed in our sources · 15 trials (lead sponsor)

• Amylyx Pharmaceuticals Clinical Phase 3

  Cambridge, MA · Antisense oligonucleotides, Peptide, RNA therapeutics · No hiring observed in our sources · 13 trials (lead sponsor)

• Arnatar Therapeutics

  San Diego, CA · Antisense oligonucleotides, RNA therapeutics, RNAi / siRNA · No hiring observed in our sources

• AUM BioTech Service / Tools company

  AI drug discovery, Antisense oligonucleotides, Gene editing · No hiring observed in our sources

• AUM Lifetech Inc.

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• AusperBio Clinical Phase 2

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 4 trials (lead sponsor)

• Avidity Biosciences Clinical Phase 3

  San Diego, CA · Antisense oligonucleotides, Monoclonal antibodies, RNA therapeutics · No hiring observed in our sources · 11 trials (lead sponsor)

• Benitec Biopharma Clinical Phase 2

  Hayward, CA · Antisense oligonucleotides, Gene therapy, Gene therapy: AAV · No hiring observed in our sources · 2 trials (lead sponsor)

• Bio-Path Holdings FDA-cleared device company Clinical Phase 2

  Pittsburgh, PA · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 6 trials (lead sponsor)

• Bolden Therapeutics

  Providence, RI · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• CAMP4 Therapeutics

  Watertown, MA · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• Carnation Therapeutics

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• Glaukos FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 67 trials (lead sponsor)

• HAYA Therapeutics Clinical Phase 1

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 1 trial (lead sponsor)

• Junipero Therapeutics, Inc.

  Antisense oligonucleotides, Gene therapy, RNA therapeutics · No hiring observed in our sources

• Kardigan Clinical Phase 3

  Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 5 trials (lead sponsor)

• Novartis FDA-approved therapeutic company Clinical Phase 3

  AI drug discovery, Antisense oligonucleotides, Cell therapy · No hiring observed in our sources · 1999 trials (lead sponsor)

• NS Pharma, Inc. Clinical Phase 3

  Paramus, NJ · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 15 trials (lead sponsor)

• Oncogenuity

  Bay Harbor Islands, FL · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources

• Oncotelic Therapeutics Clinical Phase 3

  Agoura Hills, CA · Antisense oligonucleotides, RNA therapeutics, Small molecule · No hiring observed in our sources · 3 trials (lead sponsor)

• Pdx Pharmaceuticals

  Antisense oligonucleotides, RNA therapeutics, RNAi / siRNA · No hiring observed in our sources

• ProQR Therapeutics Clinical Phase 3

  Leiden, · Antisense oligonucleotides, RNA therapeutics · No hiring observed in our sources · 7 trials (lead sponsor)

• Rhino Therapeutics Inc.

  Antisense oligonucleotides, Gene therapy, Regenerative medicine & tissue · No hiring observed in our sources

• Sapu BioScience

  San Diego, CA · Antisense oligonucleotides, RNA therapeutics, Small molecule · No hiring observed in our sources

• Switch Therapeutics

  South San Francisco, CA · Antisense oligonucleotides, Gene therapy, RNA therapeutics · No hiring observed in our sources

• Tallac Therapeutics Clinical Phase 2

  Antibody-drug conjugates (ADC), Antisense oligonucleotides, Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)

Showing 34 of 34. Filter in Discover